Recent studies showcase advancements across multiple biomedical fields: a Nature Microbiology study identified key amino acid changes enhancing the yellow fever vaccine's safety and efficacy; CRISPR gene editing 'armoring' of CAR T cells shows potential against solid tumors; and spatial biology platforms like Meteor Biotech's SLACS technology enable targeted cell isolation while preserving spatial context. Additionally, targeted protein degraders gain momentum with new clinical trial data and pharmaceutical collaborations signaling growing therapeutic promise.